Delivery Order SPE2DB22D3501-SPE2DB24FWP91

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,167.54 firm fixed-price delivery order contract is for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,617.72, is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $46,495.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product, with a completion date of March 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB22D3016) valued at $11,461.54 to provide 4564249212 PREZCOBIX 800 MG-150 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FASJ8) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00, which serves as the primary contract vehicle for...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,435.15, is a delivery order for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract. The award was made on January 21, 2025, and there was no set-aside designation used....
This is a $57,504.07 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of PREZCOBIX 800 MG-150 MG TABLET 30S. The contract has an ultimate completion date of March 6, 2025 and was awarded on March 5, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the...
This federal contract award, valued at $19,016.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 25, 2025. It is not designated as a...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $127,427.56 contract is for the provision of PREZCOBIX 800 MG-150 MG tablets to support DLA Troop Support Medical programs. As a prime contractor, Amerisourcebergen Drug Corp has previously supplied pharmaceuticals, medical supplies, and distribution services to the Department of Defense. This...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The Delivery Order has a firm fixed price of $3,221.85 and a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its broader work with federal agencies, including the DLA Troop Support Medical, providing a wide range of essential...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $35,808.60 fixed-price delivery order is for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWP91
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,889.29 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S. This contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is not set aside for any specific business category. The DLA, a defense agency, is the primary customer for this contract, which involves the supply of critical pharmaceutical products to military and federal healthcare providers.

Generated 11/11/24, 9:13 AM